This treatment approach should be considered in combination with topical corticosteroids, phototherapy, or other systemic treatments in patients with psoriasis presenting positive CD antibodies (IgA anti‐tissue transglutaminase, anti‐gliadin IgA and IgG, and IgA anti‐endomysial). Here, CD79A is linked to psoriasis.